Side-by-side comparison of AI visibility scores, market position, and capabilities
Philadelphia employer primary care for blue-collar SMB workforces at $30/employee/month with in-home visits; YC-backed $25M with $16M Cherryrock Series A competing with Amazon One Medical for hourly worker healthcare.
Vitable Health is a Philadelphia-based healthcare technology company delivering in-home and virtual primary care services to small and mid-sized businesses with blue-collar and hourly workforces — providing comprehensive medical care including prescriptions, lab tests, mental health services, and care navigation at approximately $30 per employee per month, significantly below the cost of traditional employer health insurance. Founded in 2019 and backed by Y Combinator with $25 million raised including a $16 million Series A in July 2024 led by Cherryrock Capital, Vitable serves SMBs with workforces in logistics, construction, manufacturing, and home services that are systematically underserved by traditional employer benefits.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.